Effect of Garcinia Cambogia and Green Coffee Bean in Weight Reduction

Abstract

Introduction: Various studies have widely documented how weight (being overweight, underweight or obese) plays a significant role in increasing health problems and adversely affects the quality of life. Out of all the weight-related issues, obesity is the number one contributing factor for causing health problems. To overcome this factor, a trial was conducted where a drug 'Lite plus’ (Garcinia Cambogia and Green Coffee bean) was given to a select number of people for a period of three months. Materials and Methods: 'Lite Plus' is a drug which contains Garcinia cambogia 500 mg + Green Coffee Bean Extract 400 mg, with a recommended dosage of 2 tablets/day with or before meals for 3 months. Most of the patients included in our study were females suffering from obesity-related problems such as PCOs and Infertility. During the trial, all patients were given the recommended dosage of 'Lite plus', while those with diabetes had the dose amended accordingly. Results: As a result of this trial, it was found that the use of 'Lite Plus' was very effective in decreasing weight/BMI with continuous use. After 6 weeks, out of the 250 respondents participating in the trial, 232 got a reduction in their BMI, and after 12 weeks (end of the trial), 29 respondents (11.6%) reached the desired level of BMI. Conclusion: Garcinia cambogia and Green Coffee bean are effective and safe in weight reduction.

Alternativas Fitoterápicas No Controle Da Obesidade

“…Com a inibição dessa enzima, ocorre inibição da absorção da glicose intestinal, e consequentemente, redução da glicose circulante, menor atividade insulínica. Logo, os estoques de gordura passam a ser a principal fonte de energia, gerando, assim, utilização desse tecido adiposo em excesso e consequente perda de peso (GORJI et al, 2019;CHOHAN et al, 2020;NAVEED et al, 2018). GORJI et al (2019), em sua revisão sistemática envolvendo artigos que correlacionaram a utilização do extrato de café verde e ACG em pacientes obesos, portadores de síndrome metabólica, hipertensos, NAFLD e voluntários saudáveis, obtiveram resultados significativos.…”